Squatrito, M., Blacher, S., Vervier, J., Bernet, L., Camboni, A., Dolmans, M.-M., & Munaut, C. (07 January 2026). Stage-dependent sphingosine-1-phosphate pathway modulation as a therapeutic strategy in a murine model of adenomyosis. Molecular Human Reproduction, 32 (1). doi:10.1093/molehr/gaag009 |
Squatrito, M., Vervier, J., Bernet, L., Camboni, A., Dolmans, M.-M., & Munaut, C. (02 October 2025). Temporal dynamics of uterine immune microenvironment remodeling in a murine model of adenomyosis. Molecular Human Reproduction, 31 (4). doi:10.1093/molehr/gaaf057 |
Bindels, J., Bernet, L., Squatrito, M., Nisolle, M., & Munaut, C. (19 June 2025). BEZ235-Mediated PI3K/mTOR dual inhibition improves ovarian follicle survival in a preclinical model. Reproductive Biology and Endocrinology, 23 (1), 91. doi:10.1186/s12958-025-01427-7 |
Bindels, J., Squatrito, M., Bernet, L., Nisolle, M., & Munaut, C. (19 March 2025). Ovarian cryopreservation with rapamycin improves fertility restoration in a murine orthotopic transplantation model. Scientific Reports, 15 (1), 9441. doi:10.1038/s41598-025-94588-9 |
Squatrito, M., Vervier, J., Bindels, J., Bernet, L., Blacher, S., Nisolle, M., & Munaut, C. (01 May 2024). Impaired fertility in adenomyosis: a murine model reveals endometrial receptivity and progesterone resistance imbalances. Reproduction, 167 (5). doi:10.1530/REP-24-0019 |
Squatrito, M., Vervier, J., Bindels, J., Bernet, L., Nisolle, M., & Munaut, C. (29 November 2023). Unraveling Fertility Challenges in Adenomyosis: Insights from a Murine Model on Endometrial Receptivity Alterations [Paper presentation]. ESG 2023. |
Bindels, J., Squatrito, M., Bernet, L., Nisolle, M., Henry, L., & Munaut, C. (16 August 2023). The mTOR Inhibitor Rapamycin Counteracts Follicle Activation Induced by Ovarian Cryopreservation in Murine Transplantation Models. Medicina, 59 (8), 1474. doi:10.3390/medicina59081474 |